Excitation of Fluorescent Lipid Probes Accelerates Supported Lipid Bilayer Formation via Photosensitized Lipid Oxidation
Fluorescent lipid probes are commonly used to label membranes of cells and model membranes like giant vesicles, liposomes, and supported lipid bilayers (SLB). Here, we show that excitation of fluorescent lipid probes with BODIPY-like conjugates results in a significant acceleration of the rupture an...
| Veröffentlicht in: | Langmuir : the ACS journal of surfaces and colloids. - 1992. - 35(2019), 35 vom: 03. Sept., Seite 11542-11549 |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | |
| Format: | Online-Aufsatz |
| Sprache: | English |
| Veröffentlicht: |
2019
|
| Zugriff auf das übergeordnete Werk: | Langmuir : the ACS journal of surfaces and colloids |
| Schlagworte: | Journal Article Research Support, Non-U.S. Gov't |
| Zusammenfassung: | Fluorescent lipid probes are commonly used to label membranes of cells and model membranes like giant vesicles, liposomes, and supported lipid bilayers (SLB). Here, we show that excitation of fluorescent lipid probes with BODIPY-like conjugates results in a significant acceleration of the rupture and SLB formation process for unsaturated phospholipid vesicles on SiO2 surfaces. The resulting SLBs also have smaller measured masses, which is indicative of a reduction in membrane thickness and/or membrane density. The excitation of fluorescent probes with NBD and Texas Red conjugates does not accelerate the SLB formation process. In the absence of fluorescent probes or light, the inclusion of oxidized phospholipids also accelerates SLB formation. The excitation-induced acceleration caused by BODIPY-like probes is eliminated when the probes are present with saturated phospholipids not susceptible to oxidation, and it is attenuated when a lipophilic antioxidant (α-tocopherol) is present. These results suggest that BODIPY-phospholipid conjugates are photosensitizers, and their excitation causes oxidation of lipid membranes, which significantly alters membrane properties |
|---|---|
| Beschreibung: | Date Completed 30.06.2020 Date Revised 30.06.2020 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
| ISSN: | 1520-5827 |
| DOI: | 10.1021/acs.langmuir.9b01535 |